Model
Edge
Alnylam Pharmaceuticals, Inc.
0001219016
Filing Type
4
Filing Date
8/18/2025
Updated
8/19/25, 3:26 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership